SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-01-005931
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A a2038562zsc13ga.txt SC 13G/A 24570
  Complete submission text file 0000912057-01-005931.txt   26750
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043 4154281550
MICROCIDE PHARMACEUTICALS INC (Subject) CIK: 0001010915 (see all company filings)

IRS No.: 943186021 | State of Incorp.: CA
Type: SC 13G/A | Act: 34 | File No.: 005-47911 | Film No.: 1546319
SIC: 2834 Pharmaceutical Preparations